This week has seen some big developments in drug availability in Canada. I mentioned in my last post that B.C. had approved Harvoni and Solvaldi for hepatitis C treatment. Ontario followed suit today.
When I heard the news I was writing a profile of Dr. Curtis Cooper, director of the Ottawa Hospital and Regional Hepatitis Program. It seems that the Ottawa Citizen scooped me on the drug news by two hours and included some comments from Dr. Cooper. Here’s the article.
As for the profile, it will be in my book, to be published in fall 2016. That’s a long wait but less of a wait than we’ve had for these miracle cures.